Life-threatening risks associated with HLA-mismatched unrelated donor hematopoietic cell transplantation (HCT) limit its general application for the treatment of blood diseases. In CA100019, we have taken a haplotype approach to investigate the MHC as a source of untyped variation. We mapped haplotype effects of acute or chronic graft-versus-host disease (GVHD), relapse, or mortality after HLA-mismatched unrelated donor HCT to 12 single nucleotide polymorphisms (SNPs). SNP-associated risks were conferred by either patient or donor genotype or by patient-donor mismatching. Risks after transplantation increased with increasing numbers of unfavorable SNPs. SNPs affected acute GVHD independently from chronic GVHD. SNPs also lowered relapse independently of GVHD. Haplotype-specific content for candidate genes can be used clinically to assess risks in patients and to select donors with optimal MHC genetics.
The aims of CA100019 are to: 1) confirm the impact of the 12 SNPs in HLA-mismatched transplants;2) determine the content of homozygous HLA haplotypes for candidate transplant genes;3) identify specific polymorphisms associated with risks after mismatched unrelated HCT, and 4) identify risks associated with HLA mismatches. CA100019 will contribute novel information on the genes and putative pathways involved in GVHD and graft- versus-leukemia, and provide clinicians with a haplotype-based approach for optimizing HLA-mismatched unrelated donor HCT.

Public Health Relevance

We are discovering the genes that are responsible for the success of blood and marrow transplantation from unrelated donors. Information on these genes will help physicians to choose better donors and to lower risks for patients who need a transplant to cure diseases of the blood system.

Agency
National Institute of Health (NIH)
Type
Research Project (R01)
Project #
5R01CA100019-12
Application #
8716678
Study Section
Cancer Immunopathology and Immunotherapy Study Section (CII)
Program Officer
Merritt, William D
Project Start
Project End
Budget Start
Budget End
Support Year
12
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98109
Fernandez-ViƱa, Marcelo A; Wang, Tao; Lee, Stephanie J et al. (2014) Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Blood 123:1270-8
Petersdorf, Effie W; Malkki, Mari; Horowitz, Mary M et al. (2013) Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation. Blood 121:1896-905
Petersdorf, Effie W (2013) Genetics of graft-versus-host disease: the major histocompatibility complex. Blood Rev 27:1-12
Moran, D; Morishima, S; Malkki, M et al. (2013) Identification of the MICA*070 allele by sequencing and phasing. Hum Immunol 74:557-61
Morishima, Yasuo; Kawase, Takakazu; Malkki, Mari et al. (2013) Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 19:1197-203
Petersdorf, Effie W (2013) The major histocompatibility complex: a model for understanding graft-versus-host disease. Blood 122:1863-72
Woolfrey, Ann; Klein, John P; Haagenson, Michael et al. (2011) HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 17:885-92
Walter, R B; Pagel, J M; Gooley, T A et al. (2010) Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission. Leukemia 24:1276-82
Petersdorf, E W (2010) The World Marrow Donor Association: 20 years of international collaboration for the support of unrelated donor and cord blood hematopoietic cell transplantation. Bone Marrow Transplant 45:807-10
Ringden, Olle; Pavletic, Steven Z; Anasetti, Claudio et al. (2009) The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. Blood 113:3110-8

Showing the most recent 10 out of 21 publications